Date Filed | Type | Description |
02/16/2022 |
4
| Dorman H. Paul (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns:
| Granted 10,000 shares
@ $0 |
|
03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/03/2018 |
4
| Dorman H. Paul (Director) has filed a Form 4 on RXi Pharmaceuticals Corp
Txns:
| Granted 10,000 shares
@ $0 |
|
02/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
02/12/2016 |
4
| Dorman H. Paul (Director) has filed a Form 4 on RXi Pharmaceuticals Corp
Txns:
| Granted 16,666 options to buy
@ $0.2858, valued at
$4.8k
Granted 16,666 options to buy
@ $0.2858, valued at
$4.8k
|
|
06/03/2015 |
4
| Dorman H. Paul (Director) has filed a Form 4 on RXi Pharmaceuticals Corp
Txns:
| Granted 37,500 shares
@ $0.4, valued at
$15k
Granted 18,750 options to buy
@ $0.455, valued at
$8.5k
Granted 18,750 warrants
@ $0.52, valued at
$9.8k
|
|
06/02/2015 |
4
| Dorman H. Paul (Director) has filed a Form 4 on RXi Pharmaceuticals Corp
Txns:
| Granted 16,666 options to buy
@ $0.38, valued at
$6.3k
|
|
06/04/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/03/2013 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
04/22/2013 |
4
| Dorman H. Paul (Director) has filed a Form 4 on RXi Pharmaceuticals Corp
Txns:
| Granted 1,000,000 options to buy
@ $0.2395, valued at
$239.5k
|
|
04/22/2013 |
3
| Dorman H. Paul (Director) has filed a Form 3 on RXi Pharmaceuticals Corp |